Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022516
Status:
COMPLETED
Last Update Posted:
2016-09-16
First Post:
2001-08-10
Brief Title:
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| stage IA breast cancer | View |
| stage II breast cancer | View |
| stage IIIA breast cancer | View |
| stage IIIB breast cancer | View |
| stage IB breast cancer | View |
| estrogen receptor-negative breast cancer | View |
| progesterone receptor-negative breast cancer | View |
| triple-negative breast cancer | View |
| low-dose maintenance chemotherapy | View |
| stroma | View |
| angiogenesis | View |